key: cord-0020163-7sxxp221
authors: Adatia, A.; Boscarino, A.
title: Is the NHS equipped to manage complications?
date: 2021-08-27
journal: Br Dent J
DOI: 10.1038/s41415-021-3374-4
sha: c7bbd902d266543869dd1a4632ad7da6bbd67c36
doc_id: 20163
cord_uid: 7sxxp221

nan

Sir, there has been a recent rise in popularity of dermal fillers with the increased use of social media, video calling and conferencing since the start of the pandemic. 1 As personal care premises, such as beauty salons, have been able to re-open following the easing of COVID-19 restrictions, there has been a rise in the number of patients attending Accident and Emergency (A&E) departments, with vascular occlusion following the injection of filler material undertaken in these establishments.

Vascular occlusion is a rare, but severe, complication occurring due to inadvertent intravascular injection of dermal fillers, or external vascular compression. The incidence of a vascular occlusion following soft tissue augmentation with filler is 1 in 100,000. 2 It is more common in the glabella and nasal area due to the limited collateral blood flow, 3 and has the potential to result in skin necrosis and tissue death if left untreated. 2 The first-line treatment for vascular occlusion is hyaluronidase, which is a prescription-only medication; it can break down hyaluronic acid, the component found in dermal fillers. 4 Whether undertaken by medical or non-medical practitioners, it is vital that there is a clear protocol in place for the management of such complications before administering dermal filler. Many patients are referred to their local oral and maxillofacial surgery (OMFS) department once a diagnosis of vascular occlusion is made, but it is important to bear in mind that A&E departments and maxillofacial units may not necessarily be able to manage acute complications of facial aesthetic procedures. The maxillofacial dental core trainees receiving the referrals may not have advanced aesthetics knowledge and training.

In addition, the hospital may not have hyaluronidase medication readily available.

As the public continue to seek facial aesthetic treatments, post-operative A&E attendances are also likely to rise. We believe it is important that A&E and OMFS teams are trained to spot these complications and be aware of onward specialist referral pathways, as appropriate, for the patient to receive the optimum level of care that is vital in these situations.

A 

Sir, sadly, the rhetoric from Dr Kelleher and Professor Burke is not surprising, failing to address any of the issues raised in my initial response and adding nothing to the debate. 1 I made no mention of abfraction and I don't subscribe to any occlusionita tribe, whatever that may be. No treatment was undertaken on temporomandibular disorder grounds but to generate a favourable occlusion ensuring long-term success. Much is made of anterior marginal ridge preservation but current studies relate to molar/premolar teeth where occlusal forces are completely different. Simply extrapolating this data to anterior teeth is unsound.

Send your letters to the Editor, British Dental Journal, 64 Wimpole Street, London, W1G 8YS. Email bdj@bda.org. Priority will be given to letters less than 500 words long. Authors must sign the letter, which may be edited for reasons of space.

BRITISH DENTAL JOURNAL | VOLUME 231 NO. 4 | AUgUsT 27 2021 205 UPFRONT

Zoom boom' sees rise in cosmetic treatment calls

Complications of injectable fillers, Part I

Management of a vascular occlusion associated with cosmetic injections

The use of hyaluronidase in aesthetic practice (v2.4)

The story behind how Bluetooth technology got its name

Why is bluetooth called bluetooth?

Fact check: Bluetooth is actually named after the Viking king who united Denmark